nach oben

International Archives of Occupational and Environmental Health

Erschienen in:

01.11.2007 | Original Article

Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program

verfasst von: Ellen P. Donovan, Marc E. Kolanz, David A. Galbraith, Pamela S. Chapman, Dennis J. Paustenbach

Erschienen in: International Archives of Occupational and Environmental Health | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

Data from surveys of the general workforce and new employees at a beryllium manufacturer were used to evaluate the performance of the beryllium blood lymphocyte proliferation test (BeBLPT).

Methods

Over 10,000 results from nearly 2,400 participants collected over 12 years were analyzed using consistent criteria to describe the performance characteristics of the BeBLPT.

Results

Approximately 2% of new employees had at least one positive BeBLPT result at the time of hire, and approximately 1% of new employees with no known potential occupational or possible take-home exposures to beryllium were confirmed positive (two positive results) from the time of hire. Positive results were observed in some workers within weeks or months of initial exposure, and the median time to the first positive result in confirmed positive individuals was 5 months. The prevalence of positive BeBLPT results was greatest during the first year of employment with an apparent peak in months 4–8. At least one negative or borderline/negative result was observed in 100% of new workers who underwent follow-up testing after they had been confirmed positive. There was no correlation between time of employment and an increasing prevalence of confirmed positive BeBLPT results in individual surveys; however, the cumulative incidence of confirmed positive results in subsets of workers that participated in multiple surveys increased over time.

Conclusion

The detection of confirmed positive results in non-occupationally exposed persons, the apparent reversions of previously confirmed positive results, the identification of a positive BeBLPT peak prevalence period, and the variation in intra- and inter-laboratory test methods and interpretation should be considered when interpreting results from studies utilizing the BeBLPT, especially when considering worker-specific interventions. Additional research to refine the BeBLPT or develop a new test is needed to properly characterize the relationship between sensitization and subclinical or clinical indicators of chronic beryllium disease.

Agency for Toxic Substances and Disease Registry (ATSDR) (2002) Toxicological profile for beryllium (PB2003–100135). US Department of Health and Human Services, Public Health Service. Atlanta, GA

American Conference of Governmental Industrial Hygienists (ACGIH) (2002) Biological exposure index feasibility assessment for beryllium and inorganic compounds. Cincinnati, OH

American Conference of Governmental Industrial Hygienists (ACGIH) (2005) ACGIH TLV-BEI booklet. Cincinnati, OH

Bobka CA, Stewart LA, Engelken GJ, Golitz LE, Newman LS (1997) Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med 39:540–547PubMedCrossRef

Borak J (2006) The beryllium occupational exposure limit: historical origin and current inadequacy. J Occup Environ Med 48(2):109–116PubMedCrossRef

Curtis GH (1951) Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol 64:470–482PubMed

Curtis GH (1959) The diagnosis of beryllium disease, with special reference to the patch test. AMA Arch Ind Health 19:150–153PubMed

Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E (2001a) Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg 16:579–592PubMedCrossRef

Deubner DC, Goodman M, Iannuzzi J (2001b) Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16:521–526PubMedCrossRef

Fontenot AP, Maier LA (2005) Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol 26:543–549PubMedCrossRef

Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL (2002) Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol 168:3627–3634PubMed

Fontenot AP, Palmer BE, Sullivan AK, Joslin FG, Wilson CC, Maier LA, Newman LS, Kotzin BL (2005) Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest 115:2886–2893PubMedCrossRef

Hanifin JM, Epstein WL, Cline MJ (1970) In vitro studies on granulomatous hypersensitivity to beryllium. J Invest Dermatol 55:284–288PubMedCrossRef

Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K (2001) Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74:167–176PubMedCrossRef

Johnson JS, Foote K, McClean M, Cogbill G (2001) Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom. Appl Occup Environ Hyg 16:619–630PubMedCrossRef

Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS (2001) Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med 43:238–249PubMedCrossRef

Kolanz ME (2001) Introduction to beryllium: uses, regulatory history, and disease. Appl Occup Environ Hyg 16:559–567PubMedCrossRef

Kreiss K, Newman LS, Mroz MM, Campbell PA (1989) Screening blood test identifies subclinical beryllium disease. J Occup Med 31:603–608PubMedCrossRef

Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS (1993) Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 148:985–991PubMed

Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B (1996) Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med 30:16–25PubMedCrossRef

Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B (1997) Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605–612PubMedCrossRef

Maier LA (2001) Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg 16:514–520PubMedCrossRef

Middleton DC, Lewin MD, Kowalski PJ, Cox SS, Kleinbaum D (2006) The BeLPT: algorithms and implications. Am J Ind Med 49(1):36–44PubMedCrossRef

Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R (2001) Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med 43:231–237PubMedCrossRef

Newman LS, Mroz MM, Balkissoon R, Maier LA (2005) Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171:54–60PubMedCrossRef

Pott GB, Palmer BE, Sullivan AK, Silviera L, Maier LA, Newman LS, Kotzin BL, Fontenot AP (2005) Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol 115:1036–1042PubMedCrossRef

Saltini C, Amicosante M (2001) Beryllium disease. Am J Med Sci 321:89–98PubMedCrossRef

Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K (2005) Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195–205PubMedCrossRef

Shima S (1966) Beryllium hazards and the sensitization phenomenon due to beryllium exposure, with special reference to the patch test. In: Proceedings of the 15th international congress on occupational health, Vienna

Stange AW, Hilmas DE, Furman FJ, Gatliffe TR (2001) Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg 16:405–417PubMedCrossRef

Stange AW, Furman FJ, Hilmas DE (2004) The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am J Ind Med 46:453–462PubMedCrossRef

Sterner JH, Eisenbud M (1951) Epidemiology of beryllium intoxication. AMA Arch Ind Hyg Occup Med 4:123–151

US Department of Energy (DOE) (2001) Beryllium lymphocyte proliferation testing. Washington, DC

Waksman BH (1959) The diagnosis of beryllium disease, with special reference to the patch test; discussion of paper by Dr. Curtis. AMA Arch Ind Health 19:154–156PubMed

Yoshida T, Shima S, Nagaoka K, Taniwaki H, Wada A, Kurita H, Morita K (1997) A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment. Ind Health 35:374–379PubMed

Titel: Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program
verfasst von: Ellen P. Donovan
Marc E. Kolanz
David A. Galbraith
Pamela S. Chapman
Dennis J. Paustenbach
Publikationsdatum: 01.11.2007
Verlag: Springer-Verlag
Erschienen in: International Archives of Occupational and Environmental Health / Ausgabe 2/2007
Print ISSN: 0340-0131
Elektronische ISSN: 1432-1246
DOI: https://doi.org/10.1007/s00420-007-0202-3

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers

German cattle allergy study (CAS): public health relevance of cattle-allergic farmers

Particulate air pollution and vascular reactivity: the bus stop study

Biological monitoring of occupational exposure to polycyclic aromatic hydrocarbons (PAH) by determination of monohydroxylated metabolites of phenanthrene and pyrene in urine

Differences in physical workload, psychosocial factors and musculoskeletal disorders between two groups of female hospital cleaners with two diverse organizational models

Trait anxiety and modeled exposure as determinants of self-reported annoyance to sound, air pollution and other environmental factors in the home